William Harb, MD
Colon & Rectal Surgery · Nashville, TNNPI 1063528651
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Myriad Genetic Laboratories, Inc. at 51.6% of the total. Reporting peaked in 2021 at $3,878 and has fallen 87.3% since, to $492 in 2025. Among colon & rectal surgery clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $53.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$4K
- Medtronic$1K
- Braintree Laboratories, Inc.$647
- Integra Lifesciences Corporation$240
- Conmed Corporation$175
- Olympus America Inc.$127
- plus $1K from 24 others
What the payments were for
- Consulting fees$2,51333%
- Speaking & faculty fees$1,43819%
- Travel & lodging$6298%
- Food & beverage$3,07640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 3 | $3,950 |
| Medtronic(2 entities) | 21 | $1,484 |
| Braintree Laboratories, Inc. | 64 | $647 |
| Integra Lifesciences Corporation | 3 | $240 |
| Conmed Corporation | 1 | $175 |
| Olympus America Inc. | 3 | $127 |
| W. L. Gore & Associates, Inc. | 1 | $117 |
| Acell, Inc. | 2 | $108 |
| Pacira Pharmaceuticals Incorporated | 4 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| THD America, Inc. | 5 | $70 |
| Laborie Medical Technologies Corp. | 3 | $51 |
| Axonics, Inc. | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $41 |
| Johnson & Johnson | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| GI Supply, Inc. | 1 | $36 |
| Aroa Biosurgery Incorporated | 2 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Innovation Technologies Inc | 1 | $24 |
| Micro-tech Endoscopy USA, Inc. | 2 | $24 |
| Acera Surgical, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Gilead | 1 | $17 |
| QOL Medical, LLC | 1 | $17 |
| AbbVie | 1 | $16 |
| Trevena, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COLARIS$2,300
- myRisk$1,438
- INTERSTIM$872
- PreciseTumor$213
- INTERSTIM ICON$198
- AIRSEAL$175
- ACell$136
- SURGIMEND$136
- GORE SYNECOR Biomaterial$117
How this compares
$7,655 in reported general payments places this provider in the 90th percentile of 31 colon & rectal surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 18 | $15,160 |
| Colesevelam Hcl | 33 | $6,302 |
| Colestipol Hcl | 44 | $3,632 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 14 | $2,189 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 48 | $255 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $16 | $15,16018 claims |
| Braintree Laboratories, Inc.Sutab | $647 | $2,18914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 31 colon & rectal surgery providers in Tennessee.
Other colon & rectal surgery in Nashville
- Aimal KhanNashville$35K
- Sree SuryadevaraNashville$24K
- Shannon McChesneyNashville$7K
- Molly FordNashville$6K
- Christopher MascarenhasNashville$6K
- Susan BrileyNashville$2K
- Jason AstonNashville$1K
- David BeckNashville$587
- Alexander HawkinsNashville$334
- Michael HopkinsNashville$268
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.